Article
5-Amino-4-Imidazolecarboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase Polymorphisms Affect the Susceptibility to Multiple Myeloma.
Laboratory medicine - 1 Sept 2022
Wang Yu, Ling Zhian, Hu Zuojian, Gui Ying, Huang Chunni, Yao Yibin, Li Ruolin
Abstract excerpt
OBJECTIVE: The upregulation of 5-amino-4-imidazolecarboxamide ribonucleotide transformylase/IMP cyclohydrolase (ATIC) may affect tumorigenesis and multiple myeloma (MM) development. MATERIALS AND METHODS: A total of 97 patients with MM and 102 healthy control patients were included in the study. The SNaPshot technique was used to detect the ATIC gene polymorphisms. Linkage disequilibrium (LD) and haplotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
